Skip to main content

Veradermics, Inc

MANE
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001827635

In the last 90 days, Veradermics, Inc insiders filed 0 open-market purchases and 4 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $4.19B in total; superinvestors Viking Global Investors and Maverick Capital hold it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Veradermics, Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
4 insiders, $103.1M in total
Insiders trading
4
Net value
−$103.1M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Veradermics, Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Veradermics, Inc
NameTitleLast reported holdingLast filingFilings, past year
Hollander DavidChief R&D Officer9,650Sep 3, 20261
Montanova Capital, LLCDirector612,033IndirectAug 21, 20263
Cowen AaronOther: See footnotes612,033IndirectAug 21, 20263
Averill Master Fund, Ltd.Director612,033IndirectAug 21, 20263
Averill Madison Master Fund, Ltd.Director612,033IndirectAug 21, 20263
Durso Timothy AugustChief Technical Officer78,142Aug 18, 20262
Waldman Reid AlexanderChief Executive Officer170,824Aug 18, 20262
Childs John WDirector194,117IndirectAug 14, 20262
Longitude Venture Partners V, L.P.10% Owner2,053,474IndirectFeb 5, 20261
Longitude Capital Partners V, LLC10% Owner2,053,474IndirectFeb 5, 20261
Longitude 103.8 East, L.P.10% Owner2,053,474IndirectFeb 5, 20261
Longitude 103.8 East Partners, LLC10% Owner2,053,474IndirectFeb 5, 20261
Enright Patrick GDirector, 10% Owner2,053,474IndirectFeb 5, 20261
Coric VladDirector319,398IndirectFeb 5, 20261
Neumann MarkChief Commercial Officer–Feb 5, 20261
Greco Michael V.General Counsel–Feb 5, 20261
Pance KatarinaDirector–Feb 5, 20261
Carrano Dominic GabrielChief Financial Officer–Feb 5, 20261
Grant-Kels Jane M.Director2,455Feb 5, 20261
Friedman David MatthewDirector–Feb 5, 20261

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 21, 2026 (view filing)6:11 PM ETAug 192 daysMontanova Capital, LLC and 3 othersDirectorSSaleCommon stock, par value $0.00001 per share−750.0K$107.25−$80.4M−61.9%461.0K after2 lots
Aug 18, 2026 (view filing)9:10 PM ETAug 171 dayDurso Timothy AugustChief Technical OfficerSSale−43.5K$107.82−$4.69M−35.8%78.1K after5 lots10b5-1
Aug 18, 2026 (view filing)9:04 PM ETAug 171 dayWaldman Reid AlexanderChief Executive OfficerSSale−67.5K$107.86−$7.28M−28.3%170.8K after5 lots10b5-1
Aug 14, 2026 (view filing)6:01 PM ETAug 122 daysChilds John WDirectorSSale−100.0K$107.12−$10.7M−34.0%194.1K after3 lots
Feb 27, 2026 (view filing)Feb 522 daysChilds John WDirectorPPurchase+294.1K$17.00+$5.00MNew position294.1K afterAmended
Feb 9, 2026 (view filing)6:28 PM ETFeb 4-65 daysLateMontanova Capital, LLC and 3 othersDirector, 10% OwnerPPurchaseCommon stock, par value $0.00001 per share+282.7K$37.30+$10.5M+118.9%520.5K after19 lots
Feb 5, 2026 (view filing)7:03 PM ETFeb 5Same dayLongitude Venture Partners V, L.P. and 3 others10% OwnerPPurchase+1.07M$17.00+$18.3M+109.9%2.05M after2 lotsDuplicate filing
Feb 5, 2026 (view filing)Feb 5Same dayCoric VladDirectorPPurchase+117.6K$17.00+$2.00M+58.3%319.4K after2 lots
Feb 5, 2026 (view filing)Feb 5Same dayEnright Patrick GDirector, 10% OwnerPPurchase+1.07M$17.00+$18.3M+109.9%2.05M after2 lots